Elan Gets FDA OK for Prialt Painkiller
14679
Biotech company Elan Corp. reported Tuesday that the Food and Drug Administration approved its non-narcotic painkiller Prialt to treat chronic pain.
609109
FRIDAY, Sept. 14 (HealthDay News) -- The Eli Lilly drug Evista (raloxifene) has been approved by the U.S. Food and Drug Administration to reduce the risk of invasive breast cancer among postmenopausal at high risk for the disease and among postmenopausal women with osteoporosis.
658531
A federal appeals court has cleared  the way for Alpharma Inc. ALO.N to launch a generic form of  Pfizer Inc.'s PFE.N Neurontin capsules to treat epilepsy,  sending Alpharma shares sharply higher.
428303
British regulators recommended on Monday that physicians restrict the use of the anti-depressant Efexor from drugmaker Wyeth because its use could have side effects for heart health and pose other potential risks that require more careful monitoring than other drugs in the class. Wyeth said it would challenge the decision, but its shares slipped 3 percent.
718942
Cadila Healthcare Ltd said on Tuesday it received approval from U.S. health regulators for its hydroxychloroquine sulphate tablets.
577599
Sept. 8, 2004 -- A drug recently approved to treat depression has now received the FDA&#39;s approval to treat hand and leg pain caused by nerve damage in people with diabetes.
611463
German biotech firm Jerini AG said on Friday that U.S. regulators at the Food and Drug Administration have granted priority review of its Icatibant drug for the treatment of skin-swelling disease hereditary angioedema.
470175
Pharmaceuticals Corporation today announced that the US Food and Drug Administration (FDA) has approved EnablexÂ® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary
133355
Biogen Idec Inc. and Elan Corp. said yesterday that they have applied to the Food and Drug Administration for approval to sell Tysabri, a multiple sclerosis drug, to treat patients with Crohn's disease.
177936
The Food and Drug Administration (FDA) has granted a fast track review of testosterone patches for women with low sex drive, despite concerns about insufficient data and potentially misleading marketing by their manufacturer Proctor &amp; Gamble, claim two
581366
U.S. health regulators on Friday approved Medtronic Inc's new drug-eluting heart stent, the first heart device of its kind to win U.S. approval in about 4 years.
614727
The FDA is about to make it harder for drug-eluting stents to win its approval.
407814
Shares in Irish drug group Elan Corp. PLC are expected to be in demand today, as investors react to news that Antegren, its multiple sclerosis (MS) drug now known as Tysabri, was granted accelerated approval by the US FDA last night.
425560
U.S. regulators approved the first generic rival to Johnson & Johnson's Duragesic pain relief skin patch, the U.S. Food and Drug Administration said on Friday.
333819
Company says FDA has approved Cymbalta, OK&#39;d last month as antidepression, to treat diabetic pain. NEW YORK  - Eli Lilly and Co.
142092
SAN FRANCISCO (CBS.MW) -- Shares of Elan Corp. and Biogen Idec rose in after-hours trading Tuesday after Tysabri, a drug used for the treatment of multiple sclerosis, was approved by the US Food and Drug Administration.
118432
The US Food and Drug Administration (FDA) has approved the Eli Lilly drug Alimta, for the treatment of advanced non-small cell lung cancer in previously treated patients.